340.70
+2.20
+(0.65%)
At close: January 24 at 8:57:28 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 12 | 20 | 21 |
| Avg. Estimate | 6.61B | 6.02B | 23.73B | 26.9B |
| Low Estimate | 6.53B | 5.76B | 23.65B | 26.03B |
| High Estimate | 6.8B | 6.54B | 23.92B | 28.64B |
| Year Ago Sales | 5.78B | 5.03B | 20.88B | 23.73B |
| Sales Growth (year/est) | 14.20% | 19.67% | 13.64% | 13.36% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| QAA.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Initiated | B of A Securities: Buy | 1/24/2025 |
| Maintains | Stifel: Buy to Buy | 1/22/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/16/2025 |
| Initiated | Guggenheim: Neutral | 1/8/2025 |
| Maintains | Truist Securities: Buy to Buy | 12/19/2024 |
| Maintains | Stifel: Buy to Buy | 12/11/2024 |